170 related articles for article (PubMed ID: 26472437)
1. Synthesis and Conjugation of Small Interfering Ribonucleic Neutral SiRNNs.
Hamil AS; Dowdy SF
Methods Mol Biol; 2016; 1364():1-9. PubMed ID: 26472437
[TBL] [Abstract][Full Text] [Related]
2. Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications.
Meade BR; Gogoi K; Hamil AS; Palm-Apergi C; van den Berg A; Hagopian JC; Springer AD; Eguchi A; Kacsinta AD; Dowdy CF; Presente A; Lönn P; Kaulich M; Yoshioka N; Gros E; Cui XS; Dowdy SF
Nat Biotechnol; 2014 Dec; 32(12):1256-61. PubMed ID: 25402614
[TBL] [Abstract][Full Text] [Related]
3. Enzymatically Cleavable siRNA Prodrugs: a New Paradigm for the Intracellular Delivery of RNA-Based Therapeutics.
Ducho C
ChemMedChem; 2015 Oct; 10(10):1625-7. PubMed ID: 26387983
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivo.
Rajeev KG; Nair JK; Jayaraman M; Charisse K; Taneja N; O'Shea J; Willoughby JL; Yucius K; Nguyen T; Shulga-Morskaya S; Milstein S; Liebow A; Querbes W; Borodovsky A; Fitzgerald K; Maier MA; Manoharan M
Chembiochem; 2015 Apr; 16(6):903-8. PubMed ID: 25786782
[TBL] [Abstract][Full Text] [Related]
5. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing.
Nair JK; Willoughby JL; Chan A; Charisse K; Alam MR; Wang Q; Hoekstra M; Kandasamy P; Kel'in AV; Milstein S; Taneja N; O'Shea J; Shaikh S; Zhang L; van der Sluis RJ; Jung ME; Akinc A; Hutabarat R; Kuchimanchi S; Fitzgerald K; Zimmermann T; van Berkel TJ; Maier MA; Rajeev KG; Manoharan M
J Am Chem Soc; 2014 Dec; 136(49):16958-61. PubMed ID: 25434769
[TBL] [Abstract][Full Text] [Related]
6. Synthetic SiRNA Delivery: Progress and Prospects.
Roberts TC; Ezzat K; El Andaloussi S; Weinberg MS
Methods Mol Biol; 2016; 1364():291-310. PubMed ID: 26472459
[TBL] [Abstract][Full Text] [Related]
7. 5'-(E)-Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA-GalNAc Conjugates.
Parmar R; Willoughby JL; Liu J; Foster DJ; Brigham B; Theile CS; Charisse K; Akinc A; Guidry E; Pei Y; Strapps W; Cancilla M; Stanton MG; Rajeev KG; Sepp-Lorenzino L; Manoharan M; Meyers R; Maier MA; Jadhav V
Chembiochem; 2016 Jun; 17(11):985-9. PubMed ID: 27121751
[TBL] [Abstract][Full Text] [Related]
8. New light labile linker for solid phase synthesis of 2'-O-acetalester oligonucleotides and applications to siRNA prodrug development.
Johnsson R; Lackey JG; Bogojeski JJ; Damha MJ
Bioorg Med Chem Lett; 2011 Jun; 21(12):3721-5. PubMed ID: 21570286
[TBL] [Abstract][Full Text] [Related]
9. Reversal of siRNA-mediated gene silencing in vivo.
Zlatev I; Castoreno A; Brown CR; Qin J; Waldron S; Schlegel MK; Degaonkar R; Shulga-Morskaya S; Xu H; Gupta S; Matsuda S; Akinc A; Rajeev KG; Manoharan M; Maier MA; Jadhav V
Nat Biotechnol; 2018 Jul; 36(6):509-511. PubMed ID: 29786096
[TBL] [Abstract][Full Text] [Related]
10. GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.
Springer AD; Dowdy SF
Nucleic Acid Ther; 2018 Jun; 28(3):109-118. PubMed ID: 29792572
[TBL] [Abstract][Full Text] [Related]
11. Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates.
Foster DJ; Brown CR; Shaikh S; Trapp C; Schlegel MK; Qian K; Sehgal A; Rajeev KG; Jadhav V; Manoharan M; Kuchimanchi S; Maier MA; Milstein S
Mol Ther; 2018 Mar; 26(3):708-717. PubMed ID: 29456020
[TBL] [Abstract][Full Text] [Related]
12. Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity.
Janas MM; Schlegel MK; Harbison CE; Yilmaz VO; Jiang Y; Parmar R; Zlatev I; Castoreno A; Xu H; Shulga-Morskaya S; Rajeev KG; Manoharan M; Keirstead ND; Maier MA; Jadhav V
Nat Commun; 2018 Feb; 9(1):723. PubMed ID: 29459660
[TBL] [Abstract][Full Text] [Related]
13. Facile Synthesis, Geometry, and 2'-Substituent-Dependent in Vivo Activity of 5'-(E)- and 5'-(Z)-Vinylphosphonate-Modified siRNA Conjugates.
Parmar RG; Brown CR; Matsuda S; Willoughby JLS; Theile CS; Charissé K; Foster DJ; Zlatev I; Jadhav V; Maier MA; Egli M; Manoharan M; Rajeev KG
J Med Chem; 2018 Feb; 61(3):734-744. PubMed ID: 29376650
[TBL] [Abstract][Full Text] [Related]
14. siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes.
Matsuda S; Keiser K; Nair JK; Charisse K; Manoharan RM; Kretschmer P; Peng CG; V Kel'in A; Kandasamy P; Willoughby JL; Liebow A; Querbes W; Yucius K; Nguyen T; Milstein S; Maier MA; Rajeev KG; Manoharan M
ACS Chem Biol; 2015 May; 10(5):1181-7. PubMed ID: 25730476
[TBL] [Abstract][Full Text] [Related]
15. TLR9-Targeted SiRNA Delivery In Vivo.
Hossain DM; Moreira D; Zhang Q; Nechaev S; Swiderski P; Kortylewski M
Methods Mol Biol; 2016; 1364():183-96. PubMed ID: 26472451
[TBL] [Abstract][Full Text] [Related]
16. Plasma Pharmacokinetics of N-Acetylgalactosamine-Conjugated Small-Interfering Ribonucleic Acids (GalNAc-Conjugated siRNAs).
Sten S; Cardilin T; Antonsson M; Gennemark P
Clin Pharmacokinet; 2023 Dec; 62(12):1661-1672. PubMed ID: 37824025
[TBL] [Abstract][Full Text] [Related]
17. SiRNA delivery systems based on neutral cross-linked dendrimers.
Liu J; Zhou J; Luo Y
Bioconjug Chem; 2012 Feb; 23(2):174-83. PubMed ID: 22292572
[TBL] [Abstract][Full Text] [Related]
18. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver.
Wang HX; Xiong MH; Wang YC; Zhu J; Wang J
J Control Release; 2013 Mar; 166(2):106-14. PubMed ID: 23266452
[TBL] [Abstract][Full Text] [Related]
19. Development of Prodrug Type Circular siRNA for
Hagiwara K; Honma M; Harumoto T; Harada K; Sawada T; Yamamoto J; Shinohara F
Nucleic Acid Ther; 2020 Dec; 30(6):346-364. PubMed ID: 33016851
[TBL] [Abstract][Full Text] [Related]
20. Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical.
Svenson S; Case RI; Cole RO; Hwang J; Kabir SR; Lazarus D; Lim Soo P; Ng PS; Peters C; Shum P; Sweryda-Krawiec B; Tripathi S; van der Poll D; Eliasof S
Mol Pharm; 2016 Mar; 13(3):737-47. PubMed ID: 26835715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
